REGENXBIO Inc. (RGNX)
NASDAQ: RGNX · IEX Real-Time Price · USD
21.07
-1.11 (-5.00%)
At close: Mar 28, 2024, 4:00 PM
20.74
-0.33 (-1.57%)
After-hours: Mar 28, 2024, 7:25 PM EDT
REGENXBIO Market Cap
REGENXBIO has a market cap or net worth of $1.03 billion as of March 28, 2024. Its market cap has increased by 20.56% in one year.
Market Cap
1.03B
Enterprise Value
843.79M
1-Year Change
20.56%
Ranking
Category
Stock Price
$21.07
Market Cap Chart
Since September 17, 2015, REGENXBIO's market cap has increased from $749.30M to $1.03B, an increase of 37.70%. That is a compound annual growth rate of 3.82%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 28, 2024 | 936.10M | -5.00% |
Mar 27, 2024 | 985.40M | 2.36% |
Mar 26, 2024 | 962.70M | 0.36% |
Mar 25, 2024 | 959.20M | -0.87% |
Mar 22, 2024 | 967.60M | -3.20% |
Mar 21, 2024 | 999.60M | -0.05% |
Mar 20, 2024 | 1.00B | 0.54% |
Mar 19, 2024 | 994.70M | 0.26% |
Mar 18, 2024 | 992.10M | 0.64% |
Mar 15, 2024 | 985.80M | 1.56% |
Mar 14, 2024 | 970.70M | -2.76% |
Mar 13, 2024 | 998.30M | 2.23% |
Mar 12, 2024 | 976.50M | -3.81% |
Mar 11, 2024 | 1.02B | 0.45% |
Mar 8, 2024 | 1.01B | -2.07% |
Mar 7, 2024 | 1.03B | -3.21% |
Mar 6, 2024 | 1.07B | -2.48% |
Mar 5, 2024 | 1.09B | 15.22% |
Mar 4, 2024 | 949.00M | 0.81% |
Mar 1, 2024 | 941.40M | 21.50% |
Feb 29, 2024 | 774.80M | -12.36% |
Feb 28, 2024 | 884.10M | -0.60% |
Feb 27, 2024 | 889.40M | 10.24% |
Feb 26, 2024 | 806.80M | 5.34% |
Feb 23, 2024 | 765.90M | -4.18% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Sage Therapeutics | 1.12B |
Viridian Therapeutics | 1.09B |
EyePoint Pharmaceuticals | 1.08B |
Arcutis Biotherapeutics | 1.08B |
Verve Therapeutics | 1.07B |
89bio | 1.06B |
Centessa Pharmaceuticals | 1.05B |
BioCryst Pharmaceuticals | 1.03B |